European Equity pre-Market Summary - 13th August 2026: Earnings remain in focus, Maersk upgrades guidance significantly

Ex-dividend FTSE 100: Pershing Square (PSH LN), Babcock (BAB LN), GSK (GSK LN), Rio Tinto (RIO LN), Aberdeen (ABDN LN), Shell (SHEL LN), Rentokil (RTO LN), London Stock Exchange (LSEG LN), Haleon (HLN LN), IG Group (IGG LN), NatWest (NWG LN), Melrose (MRO LN), Pearson (PSON LN), IMI (IMI LN), BP (BP/ LN), HSBC (HSBA LN), Fresnillo (FRES LN), Hiscox (HSX LN), Tritax Big Box (BBOX LN) Q2 Hapag-Lloyd (HLAG GY), +0.7%: Revenue and EBITDA higher Y/Y. Raises FY26 guidance. Notes Q2 was better Q/Q, driven by significantly higher spot rates and robust demand. Pandora (PNDORA DC): Net beat, Revenue in-line. Gross margin solid, even excluding the IEEPA claim's positive benefit. Maersk (MAERSKB DC), +1.6%: Revenue, EBITDA & EBIT beat. Upgrades FY26 guidance, above market consensus. H1 RWE (RWE GY), +1.8%: adj. EBITDA, net and EPS higher Y/Y. Confirms dividend target. Adyen (ADYEN NA), +2.3%: Revenue above exp. Raises FY26 guidance. Zealand Pharma (ZEAL DC): Revenue much lower Y/Y. Maintains guidance. Agreed to sell most of its rusfertide economics to Royalty Pharma for USD 100mln. M&A EQT (EQT SS): Offered to purchase Cleanaway Waste Management (CWY AT) at a share price of AUD 3.13/shr in cash, valuing the Co. at c. AUD 6.9bln Note, the % after the Co. name and ticker is the pre-market indication via Lang und Schwarz.